Q1 2025 Holdings
Filed 2025-05-15 | 111 holdings | $4.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lakeshore Biopharma Co LTD | ORD SHS NEW | G9845F208 | $344.0K | 140,428 | 0.0% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $441.5K | 80,420 | 0.0% |
| DIH Hldg US Inc | CL A | 23290B106 | $442.9K | 1,915,000 | 0.0% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $540.0K | 250,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $548.1K | 1,141,200 | 0.0% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $564.1K | 32,400 | 0.0% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $565.0K | 933,500 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $753.5K | 550,000 | 0.0% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $940.4K | 192,700 | 0.0% |
| Biomx Inc | COM NEW | 09090D301 | $993.5K | 1,787,767 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $1.2M | 348,000 | 0.0% |
| Turnstone Biologics Corp | COM | 90042W100 | $1.3M | 3,099,265 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.3M | 1,680,580 | 0.0% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $1.4M | 605,531 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $1.5M | 821,400 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.6M | 6,776,515 | 0.0% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.8M | 573,884 | 0.0% |
| Chemomab Therapeutics LTD | SPONSORED ADS | 16385C104 | $1.9M | 1,741,273 | 0.0% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $2.0M | 116,785 | 0.0% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $2.2M | 112,500 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.2M | 28,659 | 0.1% |
| Passage BIO Inc | COM | 702712100 | $2.5M | 7,034,626 | 0.1% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $2.6M | 150,000 | 0.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $3.3M | 3,322,488 | 0.1% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $3.5M | 921,959 | 0.1% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $3.7M | 2,252,987 | 0.1% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $3.9M | 298,301 | 0.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.9M | 700,000 | 0.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $4.0M | 891,616 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $4.2M | 23,500 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $4.5M | 3,539,358 | 0.1% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $4.6M | 593,088 | 0.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.9M | 151,800 | 0.1% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $5.7M | 2,133,405 | 0.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $6.2M | 1,172,287 | 0.1% |
| Kestra MED Technologies LTD(KMTS) | SHS | G52441105 | $6.2M | 250,000 | 0.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $7.0M | 1,120,000 | 0.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $7.1M | 6,475,291 | 0.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $7.3M | 179,900 | 0.2% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $7.4M | 4,166,000 | 0.2% |
| Springworks Therapeutics IncCall | COM | 85205L107 | $7.6M | 172,600 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $7.7M | 967,000 | 0.2% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $8.1M | 100,000 | 0.2% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $8.4M | 10,909,256 | 0.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $8.4M | 5,968,451 | 0.2% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $8.6M | 11,447,140 | 0.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $9.3M | 4,180,768 | 0.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $9.5M | 325,500 | 0.2% |
| Acelyrin Inc | COM | 00445A100 | $9.9M | 4,001,711 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $10.4M | 1,018,734 | 0.2% |